Larvol Delta - Crenigacestat-LY3039478-inhibits-osteogenic-differentiation-of-human-valve-interstitial-cells-from-patients-with-aortic-valve-calcification-in-vitro

CB-103 - Cellestia Biotech

crenigacestat (LY3039478) - Eli Lilly, BMS

http://www.ncbi.nlm.nih.gov/pubmed/36247471

Oct 18, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next